One study found that taking antidepressants in pregnancy when needed reduces the risk of preterm birth by 16%. Meanwhile, the ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

Nearly all of the 10 panelists emphasized what they said were risks of the drugs. Some claimed, without evidence, that ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

As my colleague Kiera Butler has written, Kennedy has claimed, without evidence, that they can cause addiction and school ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

One panelist, Roger McFillin, a clinical psychologist, wondered aloud if women are “just naturally experiencing their ...

The FDA is spreading lies about medications people need—and starting their attack by targeting pregnant women.

The Food and Drug Administration is considering adding warning labels to antidepressants for women who are pregnant, despite ...

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...